$PSBD
Palmer Square Capital BDC Inc. Stock $psbd

$psbd Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023065607 Filed on August 10, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$14.80M	$14.20M	$9.550M
YoY Change	41.63%	48.7%
Cost Of Revenue	$13.70M
YoY Change
Gross Profit	$15.08M
YoY Change
Gross Profit Margin	101.83%
Selling, General & Admin	$546.2K
YoY Change
% of Gross Profit	3.62%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$14.24M	$13.50M	$7.222M
YoY Change	45.78%	86.88%
Operating Profit	$830.9K	-$13.24M	-$6.948M
YoY Change	-108.73%	90.59%
Interest Expense	$11.50M
YoY Change	63.92%
% of Operating Profit	1384.05%
Other Income/Expense, Net
YoY Change
Pretax Income	$33.85M
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	$33.85M	$23.94M	-$65.33M
YoY Change	-601.11%	-136.64%
Net Earnings / Revenue	228.68%	168.59%	-684.14%
Basic Earnings Per Share	$1.30	$0.94	-$2.85
Diluted Earnings Per Share	$1.30	$0.94	-$2.85
COMMON SHARES
Basic Shares Outstanding	25.79M shares	25.04M shares	22.93M shares
Diluted Shares Outstanding	26.02M shares	25.45M shares	22.93M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.411M
YoY Change
Cash & Equivalents	$3.411M	$6.737M	$99.03K
Short-Term Investments
Other Short-Term Assets	$620.2K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$12.54M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.105B
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.112B
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$12.54M
Total Long-Term Assets	$1.112B
Total Assets	$1.125B	$1.082B
YoY Change	10.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$35.23M
YoY Change
Accrued Expenses	$901.1K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$45.39M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$632.5M
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$632.5M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$45.39M
Total Long-Term Liabilities	$632.5M
Total Liabilities	$677.9M	$655.1M
YoY Change	4.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$66.41M
YoY Change	-22.84%
Common Stock	$26.67K	$25.77K
YoY Change	14.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$446.9M	$426.5M	$385.4M
YoY Change
Total Liabilities & Shareholders Equity	$1.125B	$1.082B
YoY Change	10.28%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	$33.85M	$23.94M	-$65.33M
YoY Change	-601.11%	-136.64%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$16.14M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-14.38M
YoY Change
NET CHANGE
Cash From Operating Activities	16.14M
Cash From Investing Activities
Cash From Financing Activities	-14.38M
Net Change In Cash	1.760M
YoY Change
FREE CASH FLOW
Cash From Operating Activities	$16.14M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56126
	dei	Entity Registrant Name EntityRegistrantName	Palmer Square Capital BDC Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-3665200
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1900 Shawnee Mission Parkway
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 315
	dei	Entity Address City Or Town EntityAddressCityOrTown	Mission Woods
	dei	Entity Address State Or Province EntityAddressStateOrProvince	KS
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	66205
	dei	City Area Code CityAreaCode	(816)
	dei	Local Phone Number LocalPhoneNumber	994-3200
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25794111	shares
CY2023Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1141176211	usd
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1120099935	usd
CY2023Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1062844207	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1017211732	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6736588	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1650801	usd
CY2022Q4	cik0001794776	Receivable For Sales Of Investments ReceivableForSalesOfInvestments	31014356	usd
CY2023Q2	cik0001794776	Receivable For Paydowns Of Investments ReceivableForPaydownsOfInvestments	611650	usd
CY2022Q4	cik0001794776	Receivable For Paydowns Of Investments ReceivableForPaydownsOfInvestments	136119	usd
CY2023Q2	cik0001794776	Due From Affiliates Current DueFromAffiliatesCurrent	255752	usd
CY2022Q4	cik0001794776	Due From Affiliates Current DueFromAffiliatesCurrent	234102	usd
CY2023Q2	us-gaap	Dividends Receivable DividendsReceivable	400071	usd
CY2022Q4	us-gaap	Dividends Receivable DividendsReceivable	141997	usd
CY2023Q2	us-gaap	Interest Receivable InterestReceivable	7573724	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	6465594	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	3201409	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	598327	usd
CY2023Q2	us-gaap	Assets Assets	1081623401	usd
CY2022Q4	us-gaap	Assets Assets	1057453028	usd
CY2023Q2	us-gaap	Line Of Credit LineOfCredit	627365482	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	641309417	usd
CY2023Q2	us-gaap	Payable Investment Purchase PayableInvestmentPurchase	24762596	usd
CY2022Q4	us-gaap	Payable Investment Purchase PayableInvestmentPurchase	42750748	usd
CY2022Q4	us-gaap	Distribution Payable DistributionPayable	6941066	usd
CY2023Q2	cik0001794776	Directors Fees Payable DirectorsFeesPayable	2046014	usd
CY2022Q4	cik0001794776	Directors Fees Payable DirectorsFeesPayable	1872815	usd
CY2023Q2	cik0001794776	Selling General And Administrative Expenses SellingGeneralAndAdministrativeExpenses	920513	usd
CY2022Q4	cik0001794776	Selling General And Administrative Expenses SellingGeneralAndAdministrativeExpenses	1135500	usd
CY2023Q2	us-gaap	Liabilities Liabilities	655094605	usd
CY2022Q4	us-gaap	Liabilities Liabilities	694009546	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25772963	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25772963	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24286628	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24286628	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	25773	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	24287	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	498159589	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	473921377	usd
CY2023Q2	cik0001794776	Investment Company Distributable Earning InvestmentCompanyDistributableEarning	-71656566	usd
CY2022Q4	cik0001794776	Investment Company Distributable Earning InvestmentCompanyDistributableEarning	-110502182	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	426528796	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	363443482	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1081623401	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1057453028	usd
CY2023Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.55
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	14.96
CY2023Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	26166621	usd
CY2022Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	16391059	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	51619359	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	30548332	usd
CY2023Q2	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1142016	usd
CY2022Q2	us-gaap	Investment Income Dividend InvestmentIncomeDividend	50067	usd
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1818884	usd
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	54713	usd
CY2023Q2	us-gaap	Other Income OtherIncome	133227	usd
CY2022Q2	us-gaap	Other Income OtherIncome	56115	usd
	us-gaap	Other Income OtherIncome	189122	usd
	us-gaap	Other Income OtherIncome	149155	usd
CY2023Q2	us-gaap	Investment Income Net InvestmentIncomeNet	27441864	usd
CY2022Q2	us-gaap	Investment Income Net InvestmentIncomeNet	16497241	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	53627365	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	30752200	usd
CY2023Q2	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	27441864	usd
CY2022Q2	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	16497241	usd
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	53627365	usd
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	30752200	usd
CY2023Q2	us-gaap	Interest And Debt Expense InterestAndDebtExpense	10874884	usd
CY2022Q2	us-gaap	Interest And Debt Expense InterestAndDebtExpense	4428234	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	21197013	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	7579246	usd
CY2023Q2	us-gaap	Management Fee Expense ManagementFeeExpense	2046014	usd
CY2022Q2	us-gaap	Management Fee Expense ManagementFeeExpense	2197833	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	3958241	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	4455795	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	207282	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	139978	usd
	us-gaap	Professional Fees ProfessionalFees	419276	usd
	us-gaap	Professional Fees ProfessionalFees	278418	usd
CY2023Q2	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	18699	usd
CY2022Q2	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	18699	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	37192	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	37192	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	350618	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	437693	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	717624	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	738420	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	13497497	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	7222437	usd
	us-gaap	Operating Expenses OperatingExpenses	26329346	usd
	us-gaap	Operating Expenses OperatingExpenses	13089071	usd
CY2023Q2	us-gaap	Other Operating Income OtherOperatingIncome	255752	usd
CY2022Q2	us-gaap	Other Operating Income OtherOperatingIncome	274729	usd
	us-gaap	Other Operating Income OtherOperatingIncome	494780	usd
	us-gaap	Other Operating Income OtherOperatingIncome	556974	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-13241745	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6947708	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-25834566	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12532097	usd
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	14200119	usd
CY2022Q2	us-gaap	Net Investment Income NetInvestmentIncome	9549533	usd
	us-gaap	Net Investment Income NetInvestmentIncome	27792799	usd
	us-gaap	Net Investment Income NetInvestmentIncome	18220103	usd
CY2023Q2	cik0001794776	Non Affiliate Non Control Investments NonAffiliateNonControlInvestments	-2570	usd
CY2022Q2	cik0001794776	Non Affiliate Non Control Investments NonAffiliateNonControlInvestments	-486754	usd
	cik0001794776	Non Affiliate Non Control Investments NonAffiliateNonControlInvestments	-320015	usd
	cik0001794776	Non Affiliate Non Control Investments NonAffiliateNonControlInvestments	-856624	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-2570	usd
CY2022Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-486754	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-320015	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-856624	usd
CY2023Q2	cik0001794776	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	-9743113	usd
CY2022Q2	cik0001794776	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	74394896	usd
	cik0001794776	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	-24556200	usd
	cik0001794776	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	86126397	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	9743113	usd
CY2022Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-74394896	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	24556200	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-86126397	usd
CY2023Q2	cik0001794776	Net Realized And Unrealized Gainloss On Investments NetRealizedAndUnrealizedGainlossOnInvestments	9740543	usd
CY2022Q2	cik0001794776	Net Realized And Unrealized Gainloss On Investments NetRealizedAndUnrealizedGainlossOnInvestments	-74881650	usd
	cik0001794776	Net Realized And Unrealized Gainloss On Investments NetRealizedAndUnrealizedGainlossOnInvestments	24236185	usd
	cik0001794776	Net Realized And Unrealized Gainloss On Investments NetRealizedAndUnrealizedGainlossOnInvestments	-86983021	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	23940662	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-65332117	usd
	us-gaap	Net Income Loss NetIncomeLoss	52028984	usd
	us-gaap	Net Income Loss NetIncomeLoss	-68762918	usd
CY2023Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.56
CY2022Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.42
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	1.11
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.8
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.94
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.85
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.08
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-3.01
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25453970	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22932390	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25025158	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22870423	shares
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	14200119	usd
CY2022Q2	us-gaap	Net Investment Income NetInvestmentIncome	9549533	usd
	us-gaap	Net Investment Income NetInvestmentIncome	27792799	usd
	us-gaap	Net Investment Income NetInvestmentIncome	18220103	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-2570	usd
CY2022Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-486754	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-320015	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-856624	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	9743113	usd
CY2022Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-74394896	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	24556200	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-86126397	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	23940662	usd
CY2022Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-65332117	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	52028984	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-68762918	usd
CY2023Q2	cik0001794776	Dividends And Distributions To Stockholders DividendsAndDistributionsToStockholders	-13183368	usd
CY2022Q2	cik0001794776	Dividends And Distributions To Stockholders DividendsAndDistributionsToStockholders	-8439969	usd
	cik0001794776	Dividends And Distributions To Stockholders DividendsAndDistributionsToStockholders	-13183368	usd
	cik0001794776	Dividends And Distributions To Stockholders DividendsAndDistributionsToStockholders	-8439969	usd
CY2023Q2	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-13183368	usd
CY2022Q2	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-8439969	usd
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-13183368	usd
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-8439969	usd
CY2023Q2	cik0001794776	Issuance Of Common Stock IssuanceOfCommonStock	-6200000	usd
	cik0001794776	Issuance Of Common Stock IssuanceOfCommonStock	-17304225	usd
	cik0001794776	Issuance Of Common Stock IssuanceOfCommonStock	-4823801	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	6935473	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	5014831	usd
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	6935473	usd
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	5014831	usd
CY2023Q2	cik0001794776	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	13135473	usd
CY2022Q2	cik0001794776	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	5014831	usd
	cik0001794776	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	24239698	usd
	cik0001794776	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	9838632	usd
CY2023Q2	cik0001794776	Total Increase Decrease In Net Assets TotalIncreaseDecreaseInNetAssets	23892767	usd
CY2022Q2	cik0001794776	Total Increase Decrease In Net Assets TotalIncreaseDecreaseInNetAssets	-68757255	usd
	cik0001794776	Total Increase Decrease In Net Assets TotalIncreaseDecreaseInNetAssets	63085314	usd
	cik0001794776	Total Increase Decrease In Net Assets TotalIncreaseDecreaseInNetAssets	-67364255	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	402636029	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	454190588	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	363443482	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	452797588	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	426528796	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	385433333	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	426528796	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	385433333	usd
	us-gaap	Profit Loss ProfitLoss	52028984	usd
	us-gaap	Profit Loss ProfitLoss	-68762918	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-320015	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-856624	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	24556200	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-86126397	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	856346	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	247902	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	360234199	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	234006408	usd
	cik0001794776	Purchases Of Portfolio Investments PurchasesOfPortfolioInvestments	110130547	usd
	cik0001794776	Purchases Of Portfolio Investments PurchasesOfPortfolioInvestments	221385705	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	313870724	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	286171413	usd
	cik0001794776	Proceeds From Sale Of Portfolio Investments ProceedsFromSaleOfPortfolioInvestments	135954079	usd
	cik0001794776	Proceeds From Sale Of Portfolio Investments ProceedsFromSaleOfPortfolioInvestments	204224871	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	494302	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	490060	usd
	cik0001794776	Increasedecrease In Receivable For Sales Of Investments IncreasedecreaseInReceivableForSalesOfInvestments	-31014356	usd
	cik0001794776	Increasedecrease In Receivable For Sales Of Investments IncreasedecreaseInReceivableForSalesOfInvestments	-3640199	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	1366204	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	2515729	usd
	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	21650	usd
	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	-6011	usd
	cik0001794776	Increasedecrease In Receivable For Paydowns Of Investments IncreasedecreaseInReceivableForPaydownsOfInvestments	475531	usd
	cik0001794776	Increasedecrease In Receivable For Paydowns Of Investments IncreasedecreaseInReceivableForPaydownsOfInvestments	1188404	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2603082	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	193537	usd
	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	-2586844	usd
	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	-419535	usd
	cik0001794776	Increasedecrease In Payable For Investments Purchased IncreasedecreaseInPayableForInvestmentsPurchased	17988152	usd
	cik0001794776	Increasedecrease In Payable For Investments Purchased IncreasedecreaseInPayableForInvestmentsPurchased	66063523	usd
	cik0001794776	Increasedecrease In Management Fees Payable IncreasedecreaseInManagementFeesPayable	-173199	usd
	cik0001794776	Increasedecrease In Management Fees Payable IncreasedecreaseInManagementFeesPayable	48085	usd
	cik0001794776	Increasedecrease In Directors Fee Payable IncreasedecreaseInDirectorsFeePayable	669	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-214987	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-1540689	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	17995605	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14018459	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	10500000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	84500000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	27500000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	67000000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	25082	usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	13188961	usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	9299819	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17304225	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4823801	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12909818	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13023982	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5085787	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-994477	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1650801	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1093503	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6736588	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99026	usd
	us-gaap	Interest Paid Net InterestPaidNet	18610169	usd
	us-gaap	Interest Paid Net InterestPaidNet	7159711	usd
	cik0001794776	Distributions Declared During The Period DistributionsDeclaredDuringThePeriod	13183368	usd
	cik0001794776	Distributions Declared During The Period DistributionsDeclaredDuringThePeriod	8439969	usd
	cik0001794776	Reinvestment Of Distributions During The Period ReinvestmentOfDistributionsDuringThePeriod	6935473	usd
	cik0001794776	Reinvestment Of Distributions During The Period ReinvestmentOfDistributionsDuringThePeriod	5014831	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Use of Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Actual results could differ from those estimates.</p>
	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Indemnifications</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the normal course of business, the Company enters into contracts that contain a variety of representations which provide general indemnifications. The Company’s maximum exposure under these arrangements cannot be known; however, the Company expects any risk of loss to be remote.</p>
CY2022	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	100000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2400000	usd
CY2022	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	2500000	usd
CY2022Q4	cik0001794776	Consolidated Statements Of Assets And Liabilities ConsolidatedStatementsOfAssetsAndLiabilities	641300000	usd
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	3100000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1900000	usd
	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	5100000	usd
CY2023Q2	cik0001794776	Consolidated Statements Of Assets And Liabilities ConsolidatedStatementsOfAssetsAndLiabilities	627400000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.90	pure
	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	1.50	pure
	us-gaap	Quarterly Financial Information Income Taxes Significant Variation Description QuarterlyFinancialInformationIncomeTaxesSignificantVariationDescription	In order for the Company not to be subject to U.S. federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its net ordinary income (taking into account certain deferrals and elections) for the calendar year, (ii) 98.2% of its capital gains in excess of capital losses for the one year period ending October 31 in such calendar year and (iii) any net ordinary income and capital gains in excess of capital losses for preceding years that were not distributed during such years. The Company, at its discretion, may carry forward taxable income in excess of calendar year dividends and pay a 4% nondeductible U.S. federal excise tax on this income.
CY2023Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	1.68	pure
CY2023Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.02	pure
	us-gaap	Management Fee Description ManagementFeeDescription	The Investment Advisor, however, has agreed to waive its right to receive management fees in excess of 1.75% of the total net assets during any period prior to the listing of the Company’s common stock on a national securities exchange (a “Listing”).
	us-gaap	Incentive Fee Description IncentiveFeeDescription	The Company will pay the Investment Advisor an Income Incentive Fee with respect to its “adjusted net investment income” in each calendar quarter as follows: ● no Income Incentive Fee in any calendar quarter in which the Company’s “adjusted net investment income” does not exceed an amount equal to a “hurdle rate” of 1.5% per quarter (6% annualized) of the Company’s total net assets at the end of that quarter (the “Hurdle Amount”); ● 100% of the Company’s “adjusted net investment income” with respect to that portion of such “adjusted net investment income,” if any, that exceeds the Hurdle Amount but is less than or equal to an amount (the “Catch-Up Amount”) determined on a quarterly basis by multiplying 1.6875% by the Company’s total net asset value for the immediately preceding calendar quarter. The Catch-Up Amount is intended to provide the Investment Advisor with an incentive fee of 12.5% on all of the Company’s “adjusted net investment income” when the Company’s “adjusted net investment income” reaches the Catch-Up Amount in any calendar quarter; and ● for any calendar quarter in which the Company’s “adjusted net investment income” exceeds the Catch-Up Amount, the Income Incentive Fee shall equal 12.5% of the amount of the Company’s “adjusted net investment income” for the calendar quarter.
	cik0001794776	Longterm Investment Portfolio Percentage LongtermInvestmentPortfolioPercentage	0.138	pure
	cik0001794776	Amortized Cost Rate AmortizedCostRate	0.138	pure
CY2022	cik0001794776	Longterm Investment Portfolio Percentage LongtermInvestmentPortfolioPercentage	0.16	pure
CY2022	cik0001794776	Amortized Cost Rate AmortizedCostRate	0.163	pure
CY2023Q2	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.123	pure
CY2022Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.149	pure
CY2023Q2	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Percentage FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPercentage	1	pure
CY2022Q4	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Percentage FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPercentage	1	pure
CY2023Q2	us-gaap	Investments Investments	1062844207	usd
CY2022Q4	us-gaap	Investments Investments	1017211732	usd
CY2023Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1063000.000	usd
	us-gaap	Line Of Credit Facility Increase Accrued Interest LineOfCreditFacilityIncreaseAccruedInterest	2683000	usd
CY2023Q2	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	150000000	usd
	us-gaap	Line Of Credit Facility Description LineOfCreditFacilityDescription	(2)The carrying value of the WF Credit Facility is presented net of deferred financing costs of $1.047 million and accrued interest of $1.880 million.
CY2023Q2	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0	pure
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1486335	shares
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	24200000	usd
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	492018	shares
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	9800000	usd
	cik0001794776	Unfunded Commitments UnfundedCommitments	1500000	usd
CY2022	cik0001794776	Unfunded Commitments UnfundedCommitments	2600000	usd
CY2023Q2	us-gaap	Other Commitment OtherCommitment	1499933	usd
CY2022Q4	us-gaap	Other Commitment OtherCommitment	2636943	usd
	us-gaap	Investment Company Expense Ratio Including Voluntary Fee Waiver InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver	0.0563	pure
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	23940662	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-65332117	usd
	us-gaap	Net Income Loss NetIncomeLoss	52028984	usd
	us-gaap	Net Income Loss NetIncomeLoss	-68762918	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25453970	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22932390	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25025158	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22870423	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.94
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.85
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.01
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	14.96
CY2021Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	20.06
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	1.11
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.8
	cik0001794776	Net Realized And Unrealized Gain Loss On Investments NetRealizedAndUnrealizedGainLossOnInvestments	1
	cik0001794776	Net Realized And Unrealized Gain Loss On Investments NetRealizedAndUnrealizedGainLossOnInvestments	-3.78
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	2.11
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	-2.98
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.52
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.37
	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	-0.52
	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	-0.37
CY2023Q2	cik0001794776	Net Assets Value Per Share NetAssetsValuePerShare	16.55
CY2022Q2	cik0001794776	Net Assets Value Per Share NetAssetsValuePerShare	16.71
CY2023Q2	us-gaap	Shares Outstanding SharesOutstanding	25772963	shares
CY2022Q2	us-gaap	Shares Outstanding SharesOutstanding	23062349	shares
CY2023Q2	us-gaap	Assets Net AssetsNet	426528796	usd
CY2022Q2	us-gaap	Assets Net AssetsNet	385433333	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25025158	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22870423	shares
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.1411	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.1514	pure
	cik0001794776	Portfolio Turnover PortfolioTurnover	0.11	pure
	cik0001794776	Portfolio Turnover PortfolioTurnover	0.19	pure
	us-gaap	Investment Company Expense Ratio Voluntary Fee Waiver InvestmentCompanyExpenseRatioVoluntaryFeeWaiver	0.133	pure
	us-gaap	Investment Company Expense Ratio Voluntary Fee Waiver InvestmentCompanyExpenseRatioVoluntaryFeeWaiver	0.0588	pure
	us-gaap	Investment Company Expense Ratio Including Voluntary Fee Waiver InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver	0.1305	pure
	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.1379	pure
	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.0793	pure
	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.1404	pure
	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.0818	pure
CY2022Q2	cik0001794776	Issuance Of Common Stock IssuanceOfCommonStock		usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22870423	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22932390	shares
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.94
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.08
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare
	cik0001794776	Return Of Capital ReturnOfCapital
	cik0001794776	Return Of Capital ReturnOfCapital
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001794776

Files In Submission

Name	View Source	Status
0001213900-23-065607-index-headers.html	Edgar Link	pending
0001213900-23-065607-index.html	Edgar Link	pending
0001213900-23-065607.txt	Edgar Link	pending
0001213900-23-065607-xbrl.zip	Edgar Link	pending
cik0001794776-20230630.xsd	Edgar Link	pending
f10q0623ex31-1_palmersquare.htm	Edgar Link	pending
f10q0623ex31-2_palmersquare.htm	Edgar Link	pending
f10q0623ex32-1_palmersquare.htm	Edgar Link	pending
f10q0623ex32-2_palmersquare.htm	Edgar Link	pending
f10q0623_palmersquare.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
cik0001794776-20230630_cal.xml	Edgar Link	unprocessable
cik0001794776-20230630_lab.xml	Edgar Link	unprocessable
cik0001794776-20230630_pre.xml	Edgar Link	unprocessable
cik0001794776-20230630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0623_palmersquare_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PSBD
Palmer Square Capital BDC Inc. Stock $psbd

2023 Q3 Form 10-Q Financial Statement

#000121390023065607 Filed on August 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PSBD Palmer Square Capital BDC Inc. Stock $psbd

2023 Q3 Form 10-Q Financial Statement

#000121390023065607 Filed on August 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PSBD
Palmer Square Capital BDC Inc. Stock $psbd